Literature DB >> 16611560

Mucosal delivery of vaccines in domestic animals.

Volker Gerdts1, George K Mutwiri, Suresh K Tikoo, Lorne A Babiuk.   

Abstract

Mucosal vaccination is proving to be one of the greatest challenges in modern vaccine development. Although highly beneficial for achieving protective immunity, the induction of mucosal immunity, especially in the gastro-intestinal tract, still remains a difficult task. As a result, only very few mucosal vaccines are commercially available for domestic animals. Here, we critically review various strategies for mucosal delivery of vaccines in domestic animals. This includes live bacterial and viral vectors, particulate delivery-systems such as polymers, alginate, polyphosphazenes, immune stimulating complex and liposomes, and receptor mediated-targeting strategies to the mucosal tissues. The most commonly used routes of immunization, strategies for delivering the antigen to the mucosal surfaces, and future prospects in the development of mucosal vaccines are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611560     DOI: 10.1051/vetres:2006012

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  25 in total

Review 1.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts.

Authors:  Daniel Byrd; Tohti Amet; Ningjie Hu; Jie Lan; Sishun Hu; Qigui Yu
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 3.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

4.  Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors:  Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

5.  Thermostable tag (TST) protein expression system: engineering thermotolerant recombinant proteins and vaccines.

Authors:  Jeremy M Luke; Aaron E Carnes; Ping Sun; Clague P Hodgson; David S Waugh; James A Williams
Journal:  J Biotechnol       Date:  2010-12-17       Impact factor: 3.307

6.  Immunostimulatory effects of recombinant Erysipelothrix rhusiopathiae expressing porcine interleukin-18 in mice and pigs.

Authors:  Yohsuke Ogawa; Yu Minagawa; Fang Shi; Masahiro Eguchi; Yoshihiro Muneta; Yoshihiro Shimoji
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

7.  Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas.

Authors:  Yoshihiro Shimoji; Yohsuke Ogawa; Manae Tsukio; Kazumasa Shiraiwa; Sayaka Nishikawa; Masahiro Eguchi
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

8.  Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Authors:  Karina A Pasquevich; Silvia M Estein; Clara García Samartino; Clara García Samartino; Astrid Zwerdling; Lorena M Coria; Paula Barrionuevo; Carlos A Fossati; Guillermo H Giambartolomei; Juliana Cassataro
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation.

Authors:  Jamila Elhmouzi-Younes; Anne K Storset; Preben Boysen; Fabrice Laurent; Francçoise Drouet
Journal:  Vet Res       Date:  2009-06-24       Impact factor: 3.683

10.  Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

Authors:  Xinyuan Qiao; Guiwei Li; Xiangqing Wang; Xiaojing Li; Min Liu; Yijing Li
Journal:  BMC Microbiol       Date:  2009-12-04       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.